APA (7th ed.) Citation

JW, d. B., ERA, P., A, K., JA, v. D., AM, S., PGNJ, M., . . . T, v. M. (2023). Inflammatory reactions mimic residual or recurrent lymphoma on [18F]FDG-PET/CT after CD19-directed CAR T-cell therapy. Blood advances, 7(21), 6710. https://doi.org/10.1182/bloodadvances.2023010665

Chicago Style (17th ed.) Citation

JW, de Boer, et al. "Inflammatory Reactions Mimic Residual or Recurrent Lymphoma on [18F]FDG-PET/CT After CD19-directed CAR T-cell Therapy." Blood Advances 7, no. 21 (2023): 6710. https://doi.org/10.1182/bloodadvances.2023010665.

MLA (9th ed.) Citation

JW, de Boer, et al. "Inflammatory Reactions Mimic Residual or Recurrent Lymphoma on [18F]FDG-PET/CT After CD19-directed CAR T-cell Therapy." Blood Advances, vol. 7, no. 21, 2023, p. 6710, https://doi.org/10.1182/bloodadvances.2023010665.